We are live on ! Find out more
MED icon

Medifast

215 hedge funds and large institutions have $694M invested in Medifast in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more capital inflows, than outflows

Capital inflows: $105M | Capital outflows: $42.8M

7.65% more ownership

Funds ownership: 87.18% → 94.84% (+7.7%)

4% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 72

4% less funds holding

Funds holding: 223 → 215 (-8)

41% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 39

47% less call options, than puts

Call options by funds: $10.7M | Put options by funds: $20.2M

Holders
215
Holders Change
-8
Holders Change %
-3.59%
% of All Funds
3.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
75
Reduced
72
Closed
39
Calls
$10.7​M
Puts
$20.2​M
Net Calls
-⁠$9.5​M
Net Calls Change
+$20.7​M

MED Hedge Fund Activity: Q4 2023 in Review

215 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2023, worth a combined $694M — down 4.1% from $724M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MED and 23 opened new positions — a net loss of 16 holders — while 72 trimmed existing stakes and 75 added.

The largest buyer was Man Group, opening a new position worth an estimated $15.2M. The largest seller was Millennium Management, cutting an estimated $7.88M.

  • 215 institutional investors held Medifast (MED) as of Q4 2023, down from 223 in Q3 2023.
  • Funds reported $694M of Medifast stock for Q4 2023, down 4.1% quarter-over-quarter.
  • 23 funds opened new Medifast positions in Q4 2023 and 39 closed out, a net change of -16 holders.
  • The largest Medifast buyer in Q4 2023 was Man Group, an estimated $15.2M added.
  • The largest Medifast seller in Q4 2023 was Millennium Management, an estimated $7.88M sold.

Based on aggregated 13F filings for Q4 2023.